Head and Neck Cancer Research Review, Issue 6

In this issue:

Treatment regimens in nasopharyngeal carcinoma
Chemo-radiotherapy followed by cisplatin–gemcitabine vs. cisplatin–fluorouracil in nasopharyngeal carcinoma
Nivolumab + ipilimumab vs. nivolumab alone in R/M HNSCC
Nivolumab + ipilimumab vs. EXTREME in R/M HNSCC
Docetaxel as a radiosensitiser in locally advanced HNSCC
Pembrolizumab + cabozantinib in R/M HNSCC
Staphylococcus aureus & acute radiation dermatitis in head & neck cancer
Improved survival with HPV 16/18 in sinonasal cancer
Camrelizumab + apatinib in recurrent/metastatic nasopharyngeal carcinoma
BRAF–MEK inhibition in papillary craniopharyngioma

Please login below to download this issue (PDF)